Delivery Order SPE2DR25D1053-SPE2DR26FT252
- Not listed
- The Defense Logistics Agency awarded a $3,457.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of September 30, 2025. This non-set-aside award was made on September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dexamethasone 10 mg/ml vials with a ceiling value of $1,171.69. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is to be completed by September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,619.29 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexamethasone 10 mg/mL vials. This competitively awarded, firm fixed-price delivery order is set to conclude on August 13, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,945.52 for Dexamethasone 20 mg/5 mL vials (5 mL quantity) on a firm fixed price basis. This award, issued on July 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for U.S. military...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,824.44 on August 13, 2025, to supply Dexamethasone 10mg/ml in vials (25-count units) to the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 10, 2025. The delivery order represents work performed under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Dexamethasone 20 mg/5 mL vials (5 mL unit size) under a firm fixed-price contract valued at $1,069.60. The award was competitively issued on May 30, 2025, with an ultimate completion date of June 2, 2025, and does not include a set-aside designation. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,837.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 0.5 mg/5 mL elixir (237 mL), with an ultimate completion date of August 11, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Dexamethasone 120 mg/30 mL vials. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with a ceiling value of $2,700.82 and an ultimate completion date of June 6, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of dexamethasone 10 mg/ml vials. The contract has a potential value of $1,505.20 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is issued under an indefinite delivery contract (IDC) with a...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT252Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with a ceiling value of $1,783.65 and an ultimate completion date of October 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a critical federal vendor specializing in pharmaceutical distribution and healthcare solutions for military and veteran healthcare systems. The parent IDC enables the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialized medical commodities to support military healthcare programs worldwide. The Dexamethasone delivery under this contract exemplifies the routine pharmaceutical procurement activities executed through the larger vehicle, supporting the Defense Health Agency and other federal healthcare systems with essential medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/23/25 |